Medical cannabis advocate Chuck Manansala on Monday pointed out that the Dangerous Drugs Board (DDB) had been delaying the rescheduling of the substance in its drugs list.
The petition to reclassify cannabis in its list of dangerous substances was filed with the DDB on December 6, 2022, but the advocate said that the board is yet to act on the plea.
In arguing for the substance's reclassification, Manansala cited data from the United Nations Commission on Narcotic Drugs (UN-CND), which reclassified cannabis from Schedule 4 to Schedule 1 on December 2, 2020, following a recommendation from the World Health Organization (WHO).
Schedule 4 refers to a category of drugs with no accepted medical use and are likely to be abused, which includes Fentanyl, heroin, and other opioids. According to Manansala, the WHO found that cannabis has shown both positive outcomes and a lack of significant negative effects in treating several medical conditions and their symptoms.
Read more at newsinfo.inquirer.net